COVID-19 trials registries data warehouse

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44373

Dr Meenakshi Bhakare

asstprof.respiratorymedicine1@smcw.siu.edu.in

2020-06-18

Not recruiting

RCT

Randomized

Parallel

Blind label

single-center

Treatment

Symptomatic patients infected with SARS-CoV-2 virus diagnosed on Real time PCR test, admitted to hospital.

1. Age less than 18 and more 70 years <br/ >2. Pregnant and lactating women <br/ >3. Patients not willing to give written informed consent <br/ >4. Seriously ill patients requiring intensive care <br/ >5. Known hypersensitivity to Ivermectin drug 6. Subjects who have participated in another investigational drug or research study within 30 days of screening. <br/ >7. Subjects who are using any medication or has any disease which in the judgment of the Investigator will interfere with the conduct or interpretation of the study.

2

Dr Rajkumar Nikalje

18

70

India

Mild/moderate disease at enrollment

2: Mild/moderate disease at enrollment

100

Effect of Ivermectin on eradication of virus by testing for SARS-Co-V-2 by Real time PCR testTimepoint: day 7

| Declared number of arm (2.0) differs from found arms (3.0)

Not reported

[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]